Financhill
Back

Sarepta Therapeutics Vs. GitLab Industry Stock Comparison

Sell
43

SRPT
Sarepta Therapeutics

Last Price:
$18.22
Seasonality Move:
20.21%
Buy
71

GTLB
GitLab

Last Price:
$46.36
Seasonality Move:
-5.63%
Sell
43
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $18.20. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
GitLab (GTLB) is a Buy

Is GitLab a Buy, Sell or Hold?

  • The current GitLab [GTLB] share price is $45.14. The Score for GTLB is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • GTLB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $18.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

GTLB Stock Price Chart

What is GitLab's stock price today?

  • The GitLab share price today is $45.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTLB is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.63 Sell
Relative Strength Index (14 RSI): 22.9 Sell
Chaikin Money Flow: 2644712 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.11 - 39.13) Sell
Bollinger Bands (100): (31.38 - 92.06) Sell

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 50.96 Buy
Chaikin Money Flow: -791303 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.22 - 47.22) Buy
Bollinger Bands (100): (42.18 - 58.48) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.83 Buy
20-day SMA: 26.89 Sell
50-day SMA: 38.26 Sell
200-day SMA: 91.97 Sell
8-day EMA: 18.98 Sell
20-day EMA: 24.85 Sell
50-day EMA: 37.93 Sell
200-day EMA: 79.67 Sell

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.91 Buy
20-day SMA: 44.42 Buy
50-day SMA: 46.39 Sell
200-day SMA: 54.77 Sell
8-day EMA: 44.38 Buy
20-day EMA: 44.54 Buy
50-day EMA: 46.31 Sell
200-day EMA: 51.94 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.88 per share, and an increase next year of $5.33 per share.

GitLab Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GitLab Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):